EULAR Corporate Members
EULAR is set up of four types of institutional members: scientific societies, national organisations of people with arthritis/rheumatism and health professionals as well as corporate members.
AbbVie Inc. |
UCB BioPharma SRL |
Pfizer Inc. |
Janssen Pharmaceutica NV |
Novartis Pharma AG |
Eli Lilly and Company |
AstraZeneca UK Ltd. |
GlaxoSmithKline Research and Development Ltd. |
Bristol-Myers Squibb |
Galapagos NV |
medac GmbH |
Boehringer Ingelheim International GmbH |
Amgen (Europe) GmbH |
F. Hoffmann-La Roche Ltd. |
Vifor Fresenius Medical Care Renal Pharma Ltd. |
IBSA Institut Biochimique SA |
Fresenius Kabi SwissBioSim |
Celltrion Healthcare Co. Ltd. |
Otsuka Pharmaceutical Europe Ltd. |
Biogen International GmbH |
Merck Healthcare KGaA |
Gilead Sciences Europe Ltd. |
Related Information
Application Form
EULAR Corporate membership application form
The EULAR Family
A presentation of the EULAR member organisations.
EULAR Governance
EULAR is governed by an elected board composed by 4 experts in rheumatology and one representative of each pillar (organisations representing other health professionals in rheumatology, patient organisations and scientific societies). Our activities are overseen by 5 content committees and 4 representation committees whose activities are delivered by several hundred expert rheumatology volunteers.
EULAR Communities
EULAR underscores the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs.
EULAR comprises the HPR, PARE and EMEUNET communities, which include 105 member societies / organisations, working on a variety of activities supporting EULAR objectives.